Când viaţa câştigă

Emoţie… emoţie… pe ecranul ecografului se vede un punct. Un punct care bate. Încă o mişcare şi…da! Este inima Anastasiei, o nouă viaţă ce porneşte la drum. O viaţă ce va schimba vieţi.

Anastasia s-a născut în anul 2011 în Bucureşti. A adus bucurie în familie şi multe lacrimi de fericire. Câţiva ani mai târziu Anastasia a adus şi lacrimi de neputinţă. Fără să depindă ceva de ea, fără că părinţii să poată face ceva înainte, Anastasia a aflat că suferă de tetrapareză cerebrală infantilă formă spastică distonică bilaterală, o boală cauzată de lipsa oxigenării creierului pentru un interval de timp, la naştere.

Toamna lui 2014

În casa Anastasiei este acum linişte, micuţa doarme iar părinţii ei sunt în bucătărie. Telefonul le aduce o veste neaşteptată şi în acelaşi timp greu de înţeles. Anastasia ar putea face parte din echipa celor care creează medicină viitorului. Anastasia poate fi un deschizător de drumuri, un copil care poate scrie istorie. Celulele stem recoltate de mama la naşterea ei, ar putea să fie puse la treabă şi să ajute în tratamentul de care suferă acum micuţa.

Ai putea să refuzi o asemenea ştire? Ai putea oare să spui că nu vrei să încerci? Mama Anastasiei a spus DA!

…şi aventura începe

În toamna anului 2014, Anastasia merge pentru prima dată în Polonia, la spitalul Spitalul Universitar de Copii din Cracovia, ajutată de către Biogenis, banca de celule stem unde are stocate acum şi celulele stem. Fetiţa primeşte prima infuzie cu celule stem şi pleacă acasă chiar a doua zi după intervenţie.

După doar două săptămâni, părinţii Anastasiei observă şi primele rezultate pozitive. Pentru prima dată, Anastasia spune mama, pentru că mai apoi fetiţa să poată mânca, să poată înghiţi, să-şi îmbunătăţească motricitatea. Mai are un drum lung de parcus însă speranţa a prins aripi şi merge mai departe. Anul acesta Anastasia a fost din nou în Polonia şi a mai făcut o intervenţie. Cu siguranţă vor urmă şi altele. Cu toţii ne dorim să vedem rezultatele cât mai repede, încurajaţi fiind şi de sutele de oameni care fac un tratament cu celule stem chiar acum, în grupul de bănci de celule stem din care face parte şi Biogenis, banca ce a stocat pentru prima dată celulele stem ale Anastasiei. Peste 1500 de pacienţi sunt trataţi acum în acest grup, prin terapii standard şi experimentale, încercându-se o rezolvare pentru boli precum epilepsie, Alzheimer, autism, scleroză laterală, paralizie cerebrală, scleroză multiplă, encefalopatie, orbire…

Cand viata castiga, nimic nu te mai poate opri. Cand viata castiga, te bucuri ca ai facut ce trebuia, ii inveti si pe altii si aduci bucurie la randul tau.

Poţi vedea poveştile Biogenis pe www.biogenis.ro/candviatacastiga

Biogenis, mai mult decât o bancă de celule stem.

 

Lista cu utilizări în grupul din care face parte Biogenis

No.Cell sourceType of sourceIndicationArea of medicineYearType of therapyCountryAge
1cord bloodautologousautismneurology2018experimental therapyUSA8
2cord bloodautologousautismneurology2018experimental therapyUSA6
3cord bloodautologouscerebral palsyneurology2018experimental therapyUSA1
4cord bloodallogeneic - siblingsickle cell anemiahematology2018standard therapyTurkey10
5cord bloodallogeneic - siblingtalassemia majorhematology2018standard therapyTurkey10
6cord bloodallogeneic - siblingtalassemia majorhematology2018standard therapyTurkey5
7cord bloodallogeneic - siblingautismneurology2018experimental therapyPoland3
8cord bloodallogeneic - siblingtalassemia majorhematology2018standard therapyTurkey4
9cord bloodallogeneic - siblingtalassemia majorhematology2018standard therapyTurkey4
10cord bloodallogeneic - siblingtalassemia majorhematology2018standard therapyTurkey9
11cord bloodautologousaplastic anaemiahematology2018standard therapyPoland3
12cord bloodallogeneic - siblingchronic granulomatous diseasehematology2017standard therapyTurkey3
13cord bloodautologousautismneurology2017experimental therapyPoland4
14cord bloodautologousautismneurology2017experimental therapyPoland4
15cord bloodautologousautismneurology2017experimental therapyPoland5
16cord bloodautologousautismneurology2017experimental therapyPoland7
17cord bloodautologousautismneurology2017experimental therapyPoland6
18cord bloodautologouscerebral palsyneurology2017experimental therapyPoland6
19cord bloodallogeneic - siblingrelapse of acute lymphoblastic leukemiahematology2017standard therapyPoland7
20cord bloodautologousautismneurology2017experimental therapyPoland4
21cord bloodautologouscerebral palsyneurology2017experimental therapyPoland10
22cord bloodautologouscerebral palsyneurology2017experimental therapyPoland5
23cord bloodautologouscerebral palsyneurology2017experimental therapyPoland2
24cord bloodallogeneic - siblingtalassemia majorhematology2017standard therapyTurkey4
25cord bloodallogeneic - siblingtalassemia majorhematology2017standard therapyTurkey4
26cord bloodallogeneic - siblingCD40 ligand deficiencyhematology2017standard therapyTurkey9
27cord bloodallogeneic - siblingacute lymphoblastic leukemiahematology2016standard therapyHungary7
28cord bloodautologousautismneurology2016experimental therapyPoland6
29cord bloodallogeneic - unrelatedacute myeloid leukemiahematology2016standard therapyJordan6
30cord bloodallogeneic - siblingacute lymphoblastic leukemiahematology2015standard therapyPoland4
31cord bloodautologousacute myeloid leukemiahematology2014standard therapySpain6
32cord bloodautologouscerebral palsyneurology2014experimental therapySpain4
33cord bloodallogeneic - siblingacute lymphoblastic leukemiahematology2014standard therapyTurkey7
34cord bloodallogeneic - siblingX - linked lymphoproliferative syndromehematology2013standard therapyPolandbelow 1
35cord bloodallogeneic - siblingbeta-talassemia, agranulocytosishematology2013standard therapyTurkey8
36cord bloodallogeneic - siblingacute myeloid leukemiahematology2013standard therapyPoland3
37cord bloodallogeneic - siblingaplastic anaemiahematology2013standard therapyPoland3
38cord bloodautologouscerebral palsyneurology2012experimental therapyUSA3
39cord bloodallogeneic - siblingT-acute lymphoblastic leukemiahematology2012standard therapyTurkey5
40cord bloodallogeneic - siblingtalassemia major, acute lymphoblastic leukemiahematology2012standard therapyTurkey3
41cord bloodallogeneic - siblinganaemia, talassemia majorhematology2012standard therapyTurkey6
42cord bloodallogeneic - siblingsevere aplastic anaemiahematology2012standard therapyHungary3
43cord bloodautologouscerebral palsyneurology2011experimental therapyUSA6
44cord bloodallogeneic - siblingchronic granulomatous diseasehematology2011standard therapyPoland7
45cord bloodallogeneic - siblinghistiocytosishematology2011standard therapyPoland2
46cord bloodallogeneic - siblingacute lymphoblastic leukemiahematology2011standard therapyPoland5
47cord bloodallogeneic - siblingacute myeloid leukemiahematology2011standard therapyHungary2
48cord bloodallogeneic - siblingFanconi anemiahematology2011standard therapyPoland12
49cord bloodautologouscerebral palsyneurology2010experimental therapyUSA6
50cord bloodautologouscerebral palsyneurology2010experimental therapyUSA1
51cord bloodautologouscerebral palsyneurology2010experimental therapyUSA1
52cord bloodallogeneic - siblingpre -B acute lymphoblastic leukemiahematology2010standard therapyHungary1
53cord bloodautologouscerebral palsyneurology2009experimental therapyUSA2
54cord bloodautologouscerebral palsyneurology2009experimental therapyUSA2
55cord bloodallogeneic - siblingmyelodysplastic syndromehematology2009standard therapyPoland5
56cord bloodautologouscerebral ischemianeurology2008experimental therapyPoland1
57cord bloodallogeneic - siblingacute lymphoblastic leukemiahematology2008standard therapyPoland5
58cord bloodallogeneic - siblingSCID, severe combined immunodeficiencyhematology2007standard therapyPortugal1
59cord bloodallogeneic - siblingneuroblastomahematology2007standard therapyPoland8
60cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
61cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
62cord tissue (Wharton's jelly)allo-relatedcoxarthrosisorthopedics2019experimental therapyPoland57
63cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2019experimental therapyPoland35
64cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2019experimental therapyPoland23
65cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2019experimental therapyPoland26
66cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2019experimental therapyPoland21
67cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2019experimental therapyPoland33
68cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2019experimental therapyPoland72
69cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2019experimental therapyPoland35
70cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2019experimental therapyPoland68
71cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2019experimental therapyPoland43
72cord tissue (Wharton's jelly)allo-unrelatedatrophy of the optic nervesophthalmology2019experimental therapyPoland38
73cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2019experimental therapyPoland19
74cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2019experimental therapyPoland26
75cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2019experimental therapyPoland60
76cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2019experimental therapyPoland65
77cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2019experimental therapyPoland58
78cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2019experimental therapyPoland54
79cord tissue (Wharton's jelly)allo-unrelatedautismneurology2019experimental therapyPoland5
80cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2019experimental therapyPoland39
81cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2019experimental therapyPoland11
82cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2019experimental therapyPoland3
83cord tissue (Wharton's jelly)allo-unrelatedspina bifida, epilepsyneurology2019experimental therapyPoland2
84cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2019experimental therapyPoland3
85cord tissue (Wharton's jelly)allo-unrelatedmicrocephalia, cerebellar syndrome, delayed psychomotor developmentneurology2019experimental therapyPoland7
86cord tissue (Wharton's jelly)allo-unrelatedepilepsia, encephalopathyneurology2019experimental therapyPoland8
87cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor development, Chiari malformationneurology2019experimental therapyPoland4
88cord tissue (Wharton's jelly)allo-unrelatedencephalopathy, epilepsyneurology2019experimental therapyPoland17
89cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2019experimental therapyPoland0
90cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2019experimental therapyPoland9
91cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2019experimental therapyPoland6
92cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland55
93cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2018experimental therapyPolandno data
94cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPolandno data
95cord tissue (Wharton's jelly)allo-relatedautismneurology2018experimental therapyPoland4
96cord tissue (Wharton's jelly)allo-unrelatedautism, delayed psychomotor developmentneurology2018experimental therapyPoland6
97cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland52
98cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland42
99cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland36
100cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland60
101cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurologia2018experimental therapyPoland9
102cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurologia2018experimental therapyPoland2
103cord tissue (Wharton's jelly)allo-unrelatedcartilage damageortopedia2018experimental therapyPoland56
104cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous system - syndrom Pierre-Robinneurology2018experimental therapyPoland2
105cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2018experimental therapyPoland4
106cord tissue (Wharton's jelly)allo-unrelatedhydrocephalus, myelomeningoceleneurology2018experimental therapyPoland2
107cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2018experimental therapyPoland64
108cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland6
109cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland54
110cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland5
111cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor development, epilepsianeurology2018experimental therapyPoland4
112cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland8
113cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
114cord tissue (Wharton's jelly)allo-unrelatedgenetic syndrome - deletion of part of chromosome 3neurology2018experimental therapyPoland8
115cord tissue (Wharton's jelly)allo-unrelatedgeneral hypotonia, autismneurology2018experimental therapyPoland8
116cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland6
117cord tissue (Wharton's jelly)allo-relatedcerebral palsyneurology2018experimental therapyPoland10
118cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland3
119cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland44
120cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland42
121cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland38
122cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland10
123cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland15
124cord tissue (Wharton's jelly)allo-unrelateddevelopmental delayneurology2018experimental therapyPoland5
125cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland54
126cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland56
127cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland53
128cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2018experimental therapyPoland39
129cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland46
130cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland33
131cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland12
132cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland6
133cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2018experimental therapyPoland34
134cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
135cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland3
136cord tissue (Wharton's jelly)allo-unrelatedLeber's hereditary optic neuropathyophthalmology2018experimental therapyPoland18
137cord tissue (Wharton's jelly)allo-unrelatedatrophy of the optic nervesophthalmology2018experimental therapyPoland18
138cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2018experimental therapyPoland15
139cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland34
140cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2018experimental therapyPoland4
141cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland5
142cord tissue (Wharton's jelly)allo-unrelatedepilepsia, agenesis corporis callosineurology2018experimental therapyPoland2
143cord tissue (Wharton's jelly)allo-unrelatedcongenital myasthenianeurology2018experimental therapyPoland3
144cord tissue (Wharton's jelly)allo-unrelatedcongenital myasthenianeurology2018experimental therapyPoland6
145cord tissue (Wharton's jelly)allo-unrelatedleukodystrophyneurology2018experimental therapyPoland7
146cord tissue (Wharton's jelly)allo-unrelatedleukodystrophyneurology2018experimental therapyPoland5
147cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland44
148cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland16
149cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous system- Pitt Hopkins syndromeneurology2018experimental therapyPoland10
150cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland1
151cord tissue (Wharton's jelly)allo-unrelatedmyelomeningoceleneurology2018experimental therapyPoland1
152cord tissue (Wharton's jelly)allo-unrelatedmultiple system atrophyneurology2018experimental therapyPoland61
153cord tissue (Wharton's jelly)allo-unrelatedFriedreich's ataxianeurology2018experimental therapyPoland22
154cord tissue (Wharton's jelly)allo-unrelatedneuropathyneurology2018experimental therapyPoland47
155cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland7
156cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland13
157cord tissue (Wharton's jelly)allo-unrelatedprogressive supranuclear atrophyneurology2018experimental therapyPoland62
158cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
159cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
160cord tissue (Wharton's jelly)allo-unrelatedmultiple system atrophyneurology2018experimental therapyPoland47
161cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland62
162cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland49
163cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland2
164cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland6
165cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
166cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland7
167cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland49
168cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland6
169cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland8
170cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland2
171cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland1
172cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
173cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland7
174cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2018experimental therapyPoland42
175cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland30
176cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland73
177cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2018experimental therapyPoland66
178cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland5
179cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland30
180cord tissue (Wharton's jelly)allo-unrelatedparalysisneurology2018experimental therapyPoland9
181cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland2
182cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland5
183cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland50
184cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2018experimental therapyPoland22
185cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland38
186cord tissue (Wharton's jelly)allo-unrelatedtetraparesisorthopedics2018experimental therapyPoland32
187cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland7
188cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland4
189cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland6
190cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland3
191cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland9
192cord tissue (Wharton's jelly)allo-relatedautism, congenital cytomegalyneurology2018experimental therapyPoland6
193cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland6
194cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland9
195cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland2
196cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2018experimental therapyPoland48
197cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland41
198cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland40
199cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland7
200cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland78
201cord tissue (Wharton's jelly)allo-unrelatedstrokeneurology2018experimental therapyPoland60
202cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2018experimental therapyPoland3
203cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland61
204cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland3
205cord tissue (Wharton's jelly)allo-unrelatedcerebellar syndrome, delayed psychomotor developmentneurology2018experimental therapyPoland3
206cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland1
207cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland13
208cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland6
209cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland15
210cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPoland2
211cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPoland1
212cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2018experimental therapyPoland4
213cord tissue (Wharton's jelly)allo-unrelatedstrokeneurology2018experimental therapyPoland42
214cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
215cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland3
216cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2018experimental therapyPoland43
217cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland62
218cord tissue (Wharton's jelly)allo-unrelatedbilateral edema of the optic nervesophthalmology2018experimental therapyPoland12
219cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPoland4
220cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland6
221cord tissue (Wharton's jelly)allo-unrelatedPhelan-McDermid Syndromeneurology2018experimental therapyPoland17
222cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2018experimental therapyPoland24
223cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland8
224cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPolandbelow 1
225cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland4
226cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland1
227cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland12
228cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland70
229cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland18
230cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland51
231cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, encephalopathyneurology2018experimental therapyPoland1
232cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland8
233cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland78
234cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland68
235cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2018experimental therapyPoland7
236cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2018experimental therapyPoland4
237cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland26
238cord tissue (Wharton's jelly)allo-unrelatedgeneral hypotonianeurology2018experimental therapyPoland7
239cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland5
240cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland3
241cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland1
242cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland64
243cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland7
244cord tissue (Wharton's jelly)allo-unrelatedage-related macular degenerationophthalmology2018experimental therapyPoland82
245cord tissue (Wharton's jelly)allo-unrelatedvisual pathway dysfunctionophthalmology2018experimental therapyPoland48
246cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2018experimental therapyPoland21
247cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland71
248cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland69
249cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland22
250cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland7
251cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland8
252cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland11
253cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2018experimental therapyPoland58
254cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland56
255cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2018experimental therapyPoland11
256cord tissue (Wharton's jelly)allo-unrelatedtetraparesis spasticaneurology2018experimental therapyPoland12
257cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland64
258cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland4
259cord tissue (Wharton's jelly)allo-unrelatedgeneral hypotonianeurology2018experimental therapyPoland9
260cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsy, developmental delayneurology2018experimental therapyPoland8
261cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2018experimental therapyPoland7
262cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland7
263cord tissue (Wharton's jelly)allo-unrelateddegeneration of the cartilage of the knee jointorthopedics2018experimental therapyPoland57
264cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland1
265cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland66
266cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland70
267cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland5
268cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland6
269cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland1
270cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland61
271cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland37
272cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland50
273cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland23
274cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland69
275cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland18
276cord tissue (Wharton's jelly)allo-unrelatedbrain disorder, unspecifiedneurology2018experimental therapyPoland10
277cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland85
278cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland2
279cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
280cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
281cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland1
282cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland38
283cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland7
284cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland5
285cord tissue (Wharton's jelly)allo-unrelatedWolf-Hirschhorn syndromeneurology2018experimental therapyPoland1
286cord tissue (Wharton's jelly)allo-unrelatedencephalopathy, epilepsyneurology2018experimental therapyPoland21
287cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland4
288cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPolandbelow 1
289cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPoland6
290cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland38
291cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland64
292cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2018experimental therapyPoland29
293cord tissue (Wharton's jelly)allo-unrelatedstate after encephalitis, epilepsyneurology2018experimental therapyPoland44
294cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland42
295cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland44
296cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland47
297cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland27
298cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland8
299cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
300cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland5
301cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland4
302cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
303cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland48
304cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland55
305cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland16
306cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland6
307cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland6
308cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland5
309cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2018experimental therapyPoland5
310cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland4
311cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland4
312cord tissue (Wharton's jelly)allo-unrelatedgeneral hypotonianeurology2018experimental therapyPoland2
313cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2018experimental therapyPoland48
314cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
315cord tissue (Wharton's jelly)allo-unrelatedmicrocephalianeurology2018experimental therapyPoland12
316cord tissue (Wharton's jelly)allo-unrelatedstrokeneurology2018experimental therapyPoland67
317cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPoland5
318cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland55
319cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland34
320cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland3
321cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland3
322cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland11
323cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland3
324cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2018experimental therapyPoland66
325cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland8
326cord tissue (Wharton's jelly)allo-unrelatedlack of expected normal physical development, unspecifiedneurology2018experimental therapyPoland10
327cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
328cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
329cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
330cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
331cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
332cord tissue (Wharton's jelly)allo-unrelateddiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
333cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland62
334cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2018experimental therapyPoland28
335cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland5
336cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPoland16
337cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor development, atrophy of the optic nervesneurology2018experimental therapyPoland2
338cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland11
339cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland7
340cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2018experimental therapyPoland13
341cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland6
342cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland25
343cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland64
344cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland67
345cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2018experimental therapyPoland47
346cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2018experimental therapyPoland39
347cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland5
348cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland63
349cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland64
350cord tissue (Wharton's jelly)allo-unrelatedarthrogryposis multiplex congenita, epilepsianeurology2018experimental therapyPoland6
351cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland4
352cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland49
353cord tissue (Wharton's jelly)allo-unrelatedother reduction deformities of brain, schizencephalyneurology2018experimental therapyPoland5
354cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland3
355cord tissue (Wharton's jelly)allo-unrelatedstrokeneurology2018experimental therapyPoland53
356cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland44
357cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland38
358cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland62
359cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland67
360cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2018experimental therapyPoland6
361cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
362cord tissue (Wharton's jelly)allo-unrelated allo-relatedcerebral palsyneurology2018experimental therapyPoland13
363cord tissue (Wharton's jelly)allo-unrelatedencephalopathy, cerebral palsyneurology2018experimental therapyPoland22
364cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland4
365cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland75
366cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2018experimental therapyPolandno data
367cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland66
368cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland47
369cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland64
370cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland10
371cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPoland1
372cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland9
373cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland70
374cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland40
375cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland31
376cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland60
377cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland65
378cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland65
379cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2018experimental therapyPoland22
380cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica DMDneurology2018experimental therapyPoland8
381cord tissue (Wharton's jelly)allo-unrelatedholoprosencephalianeurology2018experimental therapyPoland12
382cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland25
383cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland80
384cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland35
385cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland54
386cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland76
387cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland9
388cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland2
389cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland80
390cord tissue (Wharton's jelly)allo-unrelateddystrophia myotonicaneurology2018experimental therapyPoland27
391cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland4
392cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland75
393cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2018experimental therapyPoland34
394cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland20
395cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland61
396cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland28
397cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland45
398cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland57
399cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland57
400cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland83
401cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland35
402cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland41
403cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland67
404cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2018experimental therapyPoland7
405cord tissue (Wharton's jelly)allo-unrelateddamage to the intercondylar fissure of the right kneeorthopedics2018experimental therapyPoland40
406cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland54
407cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2018experimental therapyPoland54
408cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland6
409cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland8
410cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland2
411cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland9
412cord tissue (Wharton's jelly)allo-unrelateddevelopmental delayneurology2018experimental therapyPoland7
413cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland40
414cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2018experimental therapyPoland21
415cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland62
416cord tissue (Wharton's jelly)allo-unrelatedautismneurology2018experimental therapyPoland8
417cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland3
418cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland28
419cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland52
420cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland47
421cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2018experimental therapyPoland46
422cord tissue (Wharton's jelly)allo-unrelatedFriedreich's ataxianeurology2018experimental therapyPoland31
423cord tissue (Wharton's jelly)allo-unrelatedFriedreich's ataxianeurology2018experimental therapyPoland27
424cord tissue (Wharton's jelly)allo-unrelatedstrokeneurology2018experimental therapyPoland70
425cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland9
426cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland55
427cord tissue (Wharton's jelly)allo-unrelatedage-related macular degenerationophthalmology2018experimental therapyPoland20
428cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland34
429cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2018experimental therapyPoland44
430cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland30
431cord tissue (Wharton's jelly)allo-unrelatedage-related macular degenerationophthalmology2018experimental therapyPoland46
432cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2018experimental therapyPoland20
433cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland65
434cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland30
435cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland38
436cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland46
437cord tissue (Wharton's jelly)allo-unrelateddevelopmental delayneurology2018experimental therapyPoland14
438cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland38
439cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland51
440cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland50
441cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland59
442cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland47
443cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland66
444cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland52
445cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2018experimental therapyPoland33
446cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland3
447cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland27
448cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland34
449cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland36
450cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland55
451cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2018experimental therapyPoland39
452cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland46
453cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland32
454cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland41
455cord tissue (Wharton's jelly)allo-unrelateddegeneration of the cartilage of the knee jointorthopedics2018experimental therapyPoland34
456cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2018experimental therapyPoland1
457cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland67
458cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2018experimental therapyPoland66
459cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2018experimental therapyPoland28
460cord tissue (Wharton's jelly)allo-unrelatedmyopathyneurology2018experimental therapyPoland57
461cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2018experimental therapyPoland2
462cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland52
463cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland44
464cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland48
465cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2018experimental therapyPoland59
466cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2018experimental therapyPoland3
467cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2018experimental therapyPoland44
468cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2018experimental therapyPoland16
469cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2018experimental therapyPoland61
470cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland36
471cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2018experimental therapyPoland25
472cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland31
473cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2018experimental therapyPoland68
474cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland71
475cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland57
476cord tissue (Wharton's jelly)allo-unrelatedanterior ischemic optic neuropathyophthalmology2017experimental therapyPoland67
477cord tissue (Wharton's jelly)allo-unrelatedmoyamoya diseaseneurology2017experimental therapyPoland17
478cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPolandbelow 1
479cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2017experimental therapyPoland7
480cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland6
481cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland2
482cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland48
483cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland14
484cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2017experimental therapyPoland15
485cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2017experimental therapyPoland8
486cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland48
487cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland66
488cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2017experimental therapyPoland7
489cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland1
490cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland7
491cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland6
492cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland45
493cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland36
494cord tissue (Wharton's jelly)allo-unrelatedcerebellar ataxianeurology2017experimental therapyPoland33
495cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2017experimental therapyPoland7
496cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland8
497cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2017experimental therapyPoland2
498cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland54
499cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland6
500cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland2
501cord tissue (Wharton's jelly)allo-unrelatedcerebellar syndromeneurology2017experimental therapyPoland46
502cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland59
503cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland43
504cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland37
505cord tissue (Wharton's jelly)allo-unrelatedcartilage damageorthopedics2017experimental therapyPoland46
506cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland64
507cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland69
508cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland5
509cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland5
510cord tissue (Wharton's jelly)allo-unrelatedautism, encephalopathyneurology2017experimental therapyPoland7
511cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2017experimental therapyPoland2
512cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland52
513cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland5
514cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland17
515cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland10
516cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland65
517cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland61
518cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland78
519cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2017experimental therapyPoland29
520cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2017experimental therapyPoland24
521cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland2
522cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland10
523cord tissue (Wharton's jelly)allo-unrelatedcongenital malformations of the nervous system, unspecifiedneurology2017experimental therapyPoland8
524cord tissue (Wharton's jelly)allo-unrelatedcerebellar syndromeneurology2017experimental therapyPoland60
525cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2017experimental therapyPoland35
526cord tissue (Wharton's jelly)allo-unrelatedcerebellar syndromeneurology2017experimental therapyPoland52
527cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2017experimental therapyPoland8
528cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland1
529cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland28
530cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland60
531cord tissue (Wharton's jelly)allo-unrelatedother specific disorders of the central nervous systemneurology2017experimental therapyPoland2
532cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland85
533cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2017experimental therapyPoland66
534cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland12
535cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland8
536cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland14
537cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland38
538cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland24
539cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland11
540cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland4
541cord tissue (Wharton's jelly)allo-unrelatedspinal cord injury, tetraparesisorthopedics2017experimental therapyPoland42
542cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland5
543cord tissue (Wharton's jelly)allo-unrelatedtetraparesis spastica, epilepsianeurology2017experimental therapyPoland2
544cord tissue (Wharton's jelly)allo-unrelatedhypoxia-ischemic encephalopathyneurology2017experimental therapyPoland1
545cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2017experimental therapyPoland65
546cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland61
547cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2017experimental therapyPoland12
548cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland3
549cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2017experimental therapyPoland37
550cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland78
551cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland44
552cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland22
553cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland1
554cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland4
555cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland32
556cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2017experimental therapyPoland1
557cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland10
558cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland6
559cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland7
560cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland18
561cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor development, epilepsianeurology2017experimental therapyPoland11
562cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland9
563cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland22
564cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland43
565cord tissue (Wharton's jelly)allo-unrelatedcondition after myelitisneurology2017experimental therapyPoland34
566cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland33
567cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland78
568cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland30
569cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland77
570cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland54
571cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland2
572cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland65
573cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland47
574cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland4
575cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland3
576cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland27
577cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland4
578cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland2
579cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland3
580cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPolandno data
581cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland53
582cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland55
583cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland2
584cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland13
585cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2017experimental therapyPoland3
586cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland15
587cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland4
588cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2017experimental therapyPoland9
589cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2017experimental therapyPoland8
590cord tissue (Wharton's jelly)allo-unrelatedtetraparesisorthopedics2017experimental therapyPoland27
591cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPolandno data
592cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2017experimental therapyPoland16
593cord tissue (Wharton's jelly)allo-unrelatedatrophy of the optic nervesophthalmology2017experimental therapyPoland35
594cord tissue (Wharton's jelly)allo-unrelatedleukodystrophyneurology2017experimental therapyPoland7
595cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland53
596cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland46
597cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland59
598cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland57
599cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland62
600cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland63
601cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland4
602cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland4
603cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland3
604cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland58
605cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland25
606cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland38
607cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland56
608cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2017experimental therapyPoland10
609cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland4
610cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland2
611cord tissue (Wharton's jelly)allo-unrelatedglobal developmental delayneurology2017experimental therapyPoland7
612cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland60
613cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland49
614cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland59
615cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland68
616cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland2
617cord tissue (Wharton's jelly)allo-unrelatedmyopathy of congenital fiber type disproportion, damage to the central nervous systemneurology2017experimental therapyPoland2
618cord tissue (Wharton's jelly)allo-unrelatedepilepsia, autismneurology2017experimental therapyPoland6
619cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland5
620cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland6
621cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2017experimental therapyPoland31
622cord tissue (Wharton's jelly)allo-unrelatedDevic’s diseaseneurology2017experimental therapyPoland45
623cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland3
624cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland5
625cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland3
626cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland3
627cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland5
628cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland7
629cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland13
630cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland10
631cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland18
632cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland26
633cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2017experimental therapyPoland12
634cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland51
635cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland5
636cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland15
637cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland8
638cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2017experimental therapyPoland5
639cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland65
640cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland70
641cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland51
642cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland64
643cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2017experimental therapyPoland74
644cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland43
645cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland3
646cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /BMDneurology2017experimental therapyPoland23
647cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland76
648cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland63
649cord tissue (Wharton's jelly)allo-unrelateddystrophia myotonicaneurology2017experimental therapyPoland3
650cord tissue (Wharton's jelly)allo-unrelatedarthrogryposis multiplex congenitaneurology2017experimental therapyPoland3
651cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2017experimental therapyPoland7
652cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland2
653cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland3
654cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland8
655cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland4
656cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland39
657cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2017experimental therapyPoland30
658cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2017experimental therapyPoland2
659cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland42
660cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland33
661cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland3
662cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland4
663cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2017experimental therapyPoland56
664cord tissue (Wharton's jelly)allo-unrelatedglobal developmental delayneurology2017experimental therapyPoland4
665cord tissue (Wharton's jelly)allo-unrelateddystrophia myotonicaneurology2017experimental therapyPoland41
666cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland54
667cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland46
668cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland32
669cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2017experimental therapyPoland6
670cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland13
671cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland7
672cord tissue (Wharton's jelly)allo-unrelatedencephalopathy, cerebral palsyneurology2017experimental therapyPoland1
673cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland6
674cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland1
675cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2017experimental therapyPoland35
676cord tissue (Wharton's jelly)allo-unrelatedcondition after encephalitisneurology2017experimental therapyPoland19
677cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland49
678cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland46
679cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland6
680cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland6
681cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland4
682cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland6
683cord tissue (Wharton's jelly)allo-unrelatedcerebellar syndromeneurology2017experimental therapyPoland60
684cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2017experimental therapyPoland62
685cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2017experimental therapyPoland48
686cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland31
687cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland45
688cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland51
689cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2017experimental therapyPoland24
690cord tissue (Wharton's jelly)allo-unrelatedKrabbe diseaseneurology2017experimental therapyPoland6
691cord tissue (Wharton's jelly)allo-unrelatedhypoxia-ischemic encephalopathyneurology2017experimental therapyPoland1
692cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2017experimental therapyPoland5
693cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland3
694cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland5
695cord tissue (Wharton's jelly)allo-relatedcerebral palsyneurology2017experimental therapyPoland12
696cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland5
697cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland33
698cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland10
699cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland31
700cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland31
701cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland35
702cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland63
703cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland36
704cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland77
705cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland4
706cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland35
707cord tissue (Wharton's jelly)allo-unrelatedischemia within the optic nerveophthalmology2017experimental therapyPoland37
708cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland66
709cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2017experimental therapyPoland11
710cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2017experimental therapyPoland13
711cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland52
712cord tissue (Wharton's jelly)allo-unrelatedsyndrom IFAPhematology2017experimental therapyPoland3
713cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2017experimental therapyPoland6
714cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2017experimental therapyPoland3
715cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland7
716cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland6
717cord tissue (Wharton's jelly)allo-unrelatedhydrocephalus, neonatal cerebral leukomalacianeurology2017experimental therapyPoland2
718cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland31
719cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2017experimental therapyPoland34
720cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2017experimental therapyPoland45
721cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2017experimental therapyPoland27
722cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland52
723cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland31
724cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland37
725cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2017experimental therapyPoland24
726cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland69
727cord tissue (Wharton's jelly)allo-unrelatedno bone adhesionorthopedics2017experimental therapyPoland17
728cord tissue (Wharton's jelly)allo-unrelatedno bone adhesionorthopedics2017experimental therapyPoland14
729cord tissue (Wharton's jelly)allo-unrelatedtraumatic brain injuryneurology2017experimental therapyPoland9
730cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland15
731cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland6
732cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, epilepsyneurology2017experimental therapyPoland5
733cord tissue (Wharton's jelly)allo-unrelatedencephalopathy, cerebral palsyneurology2017experimental therapyPoland4
734cord tissue (Wharton's jelly)allo-unrelatedarthrogryposis multiplex congenitaneurology2017experimental therapyPoland1
735cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2017experimental therapyPoland37
736cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2017experimental therapyPoland1
737cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland48
738cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland40
739cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland61
740cord tissue (Wharton's jelly)allo-unrelatedchronic myeloid leukemiahematology2017experimental therapyPoland5
741cord tissue (Wharton's jelly)allo-unrelatedcongenital fiber-type disproportion myopathyneurology2017experimental therapyPoland1
742cord tissue (Wharton's jelly)allo-unrelatedcerebellar syndromeneurology2017experimental therapyPoland11
743cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland9
744cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2017experimental therapyPoland26
745cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland11
746cord tissue (Wharton's jelly)allo-unrelatedcerebral palsy, neonatal cerebral leukomalacianeurology2017experimental therapyPoland1
747cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland52
748cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland41
749cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2017experimental therapyPoland5
750cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2017experimental therapyPoland21
751cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland13
752cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland56
753cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2017experimental therapyPoland38
754cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland47
755cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland64
756cord tissue (Wharton's jelly)allo-unrelatedsyringomielianeurology2017experimental therapyPoland42
757cord tissue (Wharton's jelly)allo-unrelatedtransverse myelitisneurology2017experimental therapyPoland8
758cord tissue (Wharton's jelly)allo-unrelatedcranium bifidumneurology2017experimental therapyPoland5
759cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2017experimental therapyPoland3
760cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland28
761cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland22
762cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland59
763cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2017experimental therapyPoland18
764cord tissue (Wharton's jelly)allo-unrelatedcri du chat syndromeneurology2017experimental therapyPoland8
765cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2017experimental therapyPoland58
766cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2017experimental therapyPoland8
767cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2017experimental therapyPoland12
768cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland30
769cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland42
770cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland39
771cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland51
772cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2017experimental therapyPoland39
773cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland43
774cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2017experimental therapyPoland23
775cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland75
776cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2017experimental therapyPoland25
777cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2017experimental therapyPoland41
778cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2017experimental therapyPoland44
779cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland28
780cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland45
781cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland65
782cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland56
783cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2017experimental therapyPoland30
784cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2017experimental therapyPoland10
785cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland24
786cord tissue (Wharton's jelly)allo-unrelatedtetraparesis spasticaneurology2017experimental therapyPoland29
787cord tissue (Wharton's jelly)allo-unrelatedage-related macular degenerationophthalmology2017experimental therapyPoland33
788cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2017experimental therapyPoland31
789cord tissue (Wharton's jelly)allo-unrelatedatrophy of the optic nervesophthalmology2017experimental therapyPoland23
790cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2017experimental therapyPoland52
791cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland34
792cord tissue (Wharton's jelly)allo-unrelatedcartilage damageorthopedics2017experimental therapyPoland61
793cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland46
794cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland48
795cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland56
796cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2017experimental therapyPoland26
797cord tissue (Wharton's jelly)allo-unrelateddystrophia myotonicaneurology2017experimental therapyPoland37
798cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2017experimental therapyPoland37
799cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland49
800cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2017experimental therapyPoland58
801cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2017experimental therapyPoland34
802cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2017experimental therapyPoland44
803cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland47
804cord tissue (Wharton's jelly)allo-unrelatedautismneurology2017experimental therapyPoland7
805cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPolandno data
806cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland71
807cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland37
808cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2017experimental therapyPoland67
809cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland55
810cord tissue (Wharton's jelly)allo-unrelatedpremature ovarian failureginecology2016experimental therapyPoland34
811cord tissue (Wharton's jelly)allo-unrelatedpremature ovarian failureginecology2016experimental therapyPoland23
812cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland60
813cord tissue (Wharton's jelly)allo-unrelatedmeniscus damageorthopedics2016experimental therapyPoland35
814cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland44
815cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland38
816cord tissue (Wharton's jelly)allo-unrelatedendometrial atrophyginecology2016experimental therapyPoland39
817cord tissue (Wharton's jelly)allo-unrelatedendometrial atrophyginecology2016experimental therapyPoland37
818cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland33
819cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland31
820cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland15
821cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /BMDneurology2016experimental therapyPoland19
822cord tissue (Wharton's jelly)allo-unrelateddegeneration of the cartilage of the knee jointorthopedics2016experimental therapyPoland54
823cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPoland44
824cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland61
825cord tissue (Wharton's jelly)allo-unrelatedtetraparesisorthopedics2016experimental therapyPoland27
826cord tissue (Wharton's jelly)allo-unrelatedneurodevelopmental disordersneurology2016experimental therapyPoland4
827cord tissue (Wharton's jelly)allo-unrelatedcerebellar syndromeneurology2016experimental therapyPoland28
828cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2016experimental therapyPoland4
829cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland4
830cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland10
831cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2016experimental therapyPoland44
832cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland4
833cord tissue (Wharton's jelly)allo-unrelatedcartilage damageorthopedics2016experimental therapyPoland57
834cord tissue (Wharton's jelly)allo-unrelatedinjuries to the spinal nervesneurology2016experimental therapyPolandbelow 1
835cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland17
836cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland3
837cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2016experimental therapyPoland16
838cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2016experimental therapyPoland33
839cord tissue (Wharton's jelly)allo-unrelatedmyopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophyophthalmology2016experimental therapyPoland37
840cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2016experimental therapyPoland37
841cord tissue (Wharton's jelly)allo-unrelateddiffuse cartilage damage left medial compartment of the kneeorthopedics2016experimental therapyPoland50
842cord tissue (Wharton's jelly)allo-unrelatedpolineuropathyneurology2016experimental therapyPoland70
843cord tissue (Wharton's jelly)allo-unrelatedepileptic encephalopathyneurology2016experimental therapyPoland3
844cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2016experimental therapyPoland14
845cord tissue (Wharton's jelly)allo-unrelatedgangliosidosis t. 1neurology2016experimental therapyPoland1
846cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPolandno data
847cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland66
848cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland56
849cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland48
850cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland4
851cord tissue (Wharton's jelly)allo-unrelatedtetraparesis spasticaorthopedics2016experimental therapyPoland18
852cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2016experimental therapyPoland2
853cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland56
854cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland72
855cord tissue (Wharton's jelly)allo-unrelated allo-relatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland41
856cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland55
857cord tissue (Wharton's jelly)allo-unrelatedchondronecrosis femoral condyleorthopedics2016experimental therapyPoland54
858cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland68
859cord tissue (Wharton's jelly)allo-unrelatedtetraparesis spasticaorthopedics2016experimental therapyPoland58
860cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland13
861cord tissue (Wharton's jelly)allo-unrelatedfetal alcohol spectrum disordersneurology2016experimental therapyPoland5
862cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland20
863cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland49
864cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland51
865cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2016experimental therapyPoland41
866cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland6
867cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland16
868cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland10
869cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland6
870cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2016experimental therapyPoland15
871cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland66
872cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2016experimental therapyPoland24
873cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland9
874cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland44
875cord tissue (Wharton's jelly)allo-unrelatedchronic graft versus host diseasehematology2016experimental therapyPolandbelow 1
876cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland68
877cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland29
878cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2016experimental therapyPoland1
879cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland7
880cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland1
881cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPoland60
882cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland71
883cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland52
884cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland65
885cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2016experimental therapyPoland32
886cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland34
887cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland24
888cord tissue (Wharton's jelly)allo-unrelatedpatella cartilage damageorthopedics2016experimental therapyPoland53
889cord tissue (Wharton's jelly)allo-unrelatedatrophy of the optic nervesophthalmology2016experimental therapyPoland20
890cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPoland59
891cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPolandno data
892cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2016experimental therapyPoland4
893cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2016experimental therapyPoland2
894cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2016experimental therapyPoland3
895cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland10
896cord tissue (Wharton's jelly)allo-unrelatedpatella cartilage damageorthopedics2016experimental therapyPoland60
897cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland53
898cord tissue (Wharton's jelly)allo-unrelatedno dataophthalmology2016experimental therapyPoland66
899cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2016experimental therapyPoland31
900cord tissue (Wharton's jelly)allo-unrelatedataxia hereditarianeurology2016experimental therapyPoland69
901cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland31
902cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland37
903cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2016experimental therapyPoland17
904cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland30
905cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2016experimental therapyPoland34
906cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland59
907cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2016experimental therapyPoland3
908cord tissue (Wharton's jelly)allo-unrelateddevelopmental delayneurology2016experimental therapyPoland2
909cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2016experimental therapyPoland1
910cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland12
911cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland12
912cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland5
913cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland2
914cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland13
915cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland68
916cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPoland54
917cord tissue (Wharton's jelly)allo-unrelatedage-related macular degenerationophthalmology2016experimental therapyPoland86
918cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPoland23
919cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland61
920cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland49
921cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland47
922cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland14
923cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2016experimental therapyPoland54
924cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2016experimental therapyPoland79
925cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland3
926cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland8
927cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland38
928cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2016experimental therapyPoland66
929cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2016experimental therapyPoland7
930cord tissue (Wharton's jelly)allo-unrelateddevelopmental delayneurology2016experimental therapyPoland7
931cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland13
932cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland39
933cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland66
934cord tissue (Wharton's jelly)allo-unrelatedglobal developmental delayneurology2016experimental therapyPoland6
935cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland9
936cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland3
937cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2016experimental therapyPoland1
938cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2016experimental therapyPoland4
939cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland58
940cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland55
941cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland49
942cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland55
943cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland66
944cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland12
945cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland58
946cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland62
947cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland55
948cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2016experimental therapyPoland14
949cord tissue (Wharton's jelly)allo-unrelatedlimb-girdle muscular dystrophyneurology2016experimental therapyPoland22
950cord tissue (Wharton's jelly)allo-unrelated allo-relatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland50
951cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland54
952cord tissue (Wharton's jelly)allo-unrelatedadrenoleukodystrophyneurology2016experimental therapyPoland9
953cord tissue (Wharton's jelly)allo-unrelatedadrenoleukodystrophyneurology2016experimental therapyPoland6
954cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland48
955cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland72
956cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland79
957cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland61
958cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland45
959cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland61
960cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2016experimental therapyPoland3
961cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPoland32
962cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland48
963cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland61
964cord tissue (Wharton's jelly)allo-unrelatedleukodystrophyneurology2016experimental therapyPoland2
965cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland73
966cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland60
967cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland7
968cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPoland63
969cord tissue (Wharton's jelly)allo-unrelatedchoroideremiaophthalmology2016experimental therapyPoland50
970cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland49
971cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland41
972cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland33
973cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland54
974cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland55
975cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland4
976cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland2
977cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland51
978cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland56
979cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland62
980cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2016experimental therapyPoland2
981cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland6
982cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2016experimental therapyPoland38
983cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland64
984cord tissue (Wharton's jelly)allo-unrelatedmalformation syndromeneurology2016experimental therapyPoland3
985cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland64
986cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland61
987cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland56
988cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland54
989cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland72
990cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland46
991cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland55
992cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland49
993cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland66
994cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland59
995cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland36
996cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland53
997cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland45
998cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2016experimental therapyPoland13
999cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2016experimental therapyPoland69
1000cord tissue (Wharton's jelly)allo-unrelatedoptic atrophyophthalmology2016experimental therapyPoland69
1001cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2016experimental therapyPoland49
1002cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland9
1003cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland11
1004cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland6
1005cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2016experimental therapyPoland60
1006cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland42
1007cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2016experimental therapyPoland14
1008cord tissue (Wharton's jelly)allo-unrelatedtetraparesisorthopedics2016experimental therapyPoland27
1009cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland66
1010cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland59
1011cord tissue (Wharton's jelly)allo-unrelatedepilepsianeurology2016experimental therapyPoland19
1012cord tissue (Wharton's jelly)allo-unrelatedtraumatic brain injuryneurology2016experimental therapyPoland54
1013cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland2
1014cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland18
1015cord tissue (Wharton's jelly)allo-unrelatedtetraparesis spasticaorthopedics2016experimental therapyPoland47
1016cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2016experimental therapyPoland69
1017cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2016experimental therapyPoland34
1018cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland60
1019cord tissue (Wharton's jelly)allo-unrelatedtetraparesis spasticaorthopedics2016experimental therapyPoland28
1020cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland59
1021cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland52
1022cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland61
1023cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland58
1024cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland55
1025cord tissue (Wharton's jelly)allo-unrelatedchronic graft versus host diseasehematology2016experimental therapyPoland19
1026cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland58
1027cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland46
1028cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland53
1029cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland54
1030cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland63
1031cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland10
1032cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland25
1033cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland44
1034cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland6
1035cord tissue (Wharton's jelly)allo-unrelatedpatella cartilage damageorthopedics2016experimental therapyPoland60
1036cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland39
1037cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland8
1038cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland25
1039cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland24
1040cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland20
1041cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland33
1042cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2016experimental therapyPoland69
1043cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland28
1044cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland7
1045cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland39
1046cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland37
1047cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland33
1048cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2016experimental therapyPoland29
1049cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland8
1050cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland10
1051cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland22
1052cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2016experimental therapyPoland33
1053cord tissue (Wharton's jelly)allo-unrelatedStargardt's diseaseophthalmology2016experimental therapyPoland53
1054cord tissue (Wharton's jelly)allo-unrelatedatrophy of the optic nervesophthalmology2016experimental therapyPoland20
1055cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland9
1056cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland12
1057cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland2
1058cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland6
1059cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland59
1060cord tissue (Wharton's jelly)allo-unrelatedleukodystrophyneurology2016experimental therapyPoland2
1061cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2016experimental therapyPoland65
1062cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2016experimental therapyPoland6
1063cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2016experimental therapyPoland14
1064cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2016experimental therapyPoland3
1065cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland12
1066cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland53
1067cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland35
1068cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland10
1069cord tissue (Wharton's jelly)allo-unrelateddystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland48
1070cord tissue (Wharton's jelly)allo-unrelatedautismneurology2016experimental therapyPoland18
1071cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2016experimental therapyPoland62
1072cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2016experimental therapyPoland64
1073cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland32
1074cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland60
1075cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2016experimental therapyPoland44
1076cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2016experimental therapyPoland10
1077cord tissue (Wharton's jelly)allo-unrelatedadrenoleukodystrophy, encephalopathyneurology2015experimental therapyPoland8
1078cord tissue (Wharton's jelly)allo-unrelated allo-relatedencephalopathyneurology2015experimental therapyPoland11
1079cord tissue (Wharton's jelly)allo-unrelatedcerebellar ataxianeurology2015experimental therapyPoland26
1080cord tissue (Wharton's jelly)allo-unrelatedretinitis pigmentosaophthalmology2015experimental therapyPoland34
1081cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland16
1082cord tissue (Wharton's jelly)allo-unrelatedanterior ischemic optic neuropathyophthalmology2015experimental therapyPoland54
1083cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland14
1084cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland1
1085cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland34
1086cord tissue (Wharton's jelly)allo-unrelatedleukodystrophyneurology2015experimental therapyPoland18
1087cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2015experimental therapyPoland65
1088cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland24
1089cord tissue (Wharton's jelly)allo-unrelatedstrokeneurology2015experimental therapyPoland54
1090cord tissue (Wharton's jelly)allo-unrelatedintracranial injuryneurology2015experimental therapyPoland24
1091cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland54
1092cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland61
1093cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2015experimental therapyPoland13
1094cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland9
1095cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland21
1096cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland48
1097cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2015experimental therapyPoland6
1098cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2015experimental therapyPolandbelow 1
1099cord tissue (Wharton's jelly)allo-unrelatedautismneurology2015experimental therapyPoland8
1100cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland46
1101cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2015experimental therapyPoland26
1102cord tissue (Wharton's jelly)allo-unrelatedsevere developmental delayneurology2015experimental therapyPoland1
1103cord tissue (Wharton's jelly)allo-unrelatedchronic graft versus host diseasehematology2015experimental therapyPoland10
1104cord tissue (Wharton's jelly)allo-unrelatedfacio-scapulo-humeral muscular dystrophyneurology2015experimental therapyPoland30
1105cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland58
1106cord tissue (Wharton's jelly)allo-unrelatedstrokeneurology2015experimental therapyPoland62
1107cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland37
1108cord tissue (Wharton's jelly)allo-unrelatedpolineuropathyneurology2015experimental therapyPoland74
1109cord tissue (Wharton's jelly)allo-unrelatedautismneurology2015experimental therapyPoland5
1110cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland67
1111cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2015experimental therapyPoland24
1112cord tissue (Wharton's jelly)allo-unrelatedcerebellar ataxianeurology2015experimental therapyPoland18
1113cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2015experimental therapyPoland2
1114cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor developmentneurology2015experimental therapyPoland3
1115cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2015experimental therapyPoland33
1116cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland22
1117cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland32
1118cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland63
1119cord tissue (Wharton's jelly)allo-unrelatedautismneurology2015experimental therapyPoland4
1120cord tissue (Wharton's jelly)allo-unrelatedautismneurology2015experimental therapyPoland6
1121cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland4
1122cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland27
1123cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland26
1124cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland12
1125cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2015experimental therapyPoland51
1126cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland62
1127cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2015experimental therapyPoland45
1128cord tissue (Wharton's jelly)allo-unrelatediatrogenic spinal cord injuryneurology2015experimental therapyPoland17
1129cord tissue (Wharton's jelly)allo-unrelatedgonarthrosisorthopedics2015experimental therapyPoland66
1130cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland61
1131cord tissue (Wharton's jelly)allo-unrelatedoptic neuropathyophthalmology2015experimental therapyPoland15
1132cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2015experimental therapyPoland44
1133cord tissue (Wharton's jelly)allo-unrelatedspinal muscular atrophyneurology2015experimental therapyPolandbelow 1
1134cord tissue (Wharton's jelly)allo-unrelatedspinocerebellar ataxianeurology2015experimental therapyPoland35
1135cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland58
1136cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland37
1137cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland26
1138cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland40
1139cord tissue (Wharton's jelly)allo-unrelatedadrenoleukodystrophyneurology2015experimental therapyPoland11
1140cord tissue (Wharton's jelly)allo-unrelatedadrenoleukodystrophy, encephalopathyneurology2015experimental therapyPoland23
1141cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland2
1142cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland18
1143cord tissue (Wharton's jelly)allo-unrelatedtraumatic encephalopathyneurology2015experimental therapyPoland20
1144cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland61
1145cord tissue (Wharton's jelly)allo-unrelateddelayed psychomotor development, deafnessneurology2015experimental therapyPoland3
1146cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland8
1147cord tissue (Wharton's jelly)allo-unrelatedautismneurology2015experimental therapyPoland12
1148cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland5
1149cord tissue (Wharton's jelly)allo-unrelatedspinal cord injuryorthopedics2015experimental therapyPoland31
1150cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland59
1151cord tissue (Wharton's jelly)allo-unrelatedspina bifidaneurology2015experimental therapyPoland2
1152cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland13
1153cord tissue (Wharton's jelly)allo-unrelated allo-relatedcerebral palsyneurology2015experimental therapyPoland7
1154cord tissue (Wharton's jelly)allo-unrelatedautismneurology2015experimental therapyPoland3
1155cord tissue (Wharton's jelly)allo-unrelatedceroid lipofuscinosisneurology2015experimental therapyPoland7
1156cord tissue (Wharton's jelly)allo-unrelatedencephalopathyneurology2015experimental therapyPoland14
1157cord tissue (Wharton's jelly)allo-unrelatedceroid lipofuscinosisneurology2015experimental therapyPoland5
1158cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland15
1159cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland7
1160cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2015experimental therapyPolandbelow 1
1161cord tissue (Wharton's jelly)allo-unrelatedbilateral blindnessophthalmology2015experimental therapyPoland36
1162cord tissue (Wharton's jelly)allo-unrelateddecerebration rigidityneurology2015experimental therapyPoland9
1163cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2015experimental therapyPoland3
1164cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland52
1165cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland60
1166cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland65
1167cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland51
1168cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland56
1169cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland61
1170cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2015experimental therapyPoland61
1171cord tissue (Wharton's jelly)allo-unrelatedsclerosis multiplexneurology2015experimental therapyPoland23
1172cord tissue (Wharton's jelly)allo-unrelatedautismneurology2015experimental therapyPoland5
1173cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2015experimental therapyPoland1
1174cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2014experimental therapyPoland15
1175cord tissue (Wharton's jelly)allo-unrelatedcerebral palsyneurology2014experimental therapyPoland4
1176cord tissue (Wharton's jelly)allo-unrelatedbirth asphyxia, retinopathyneurology2014experimental therapyPolandbelow 1
1177cord tissue (Wharton's jelly)allo-unrelatedmuscular dystrophyneurology2014experimental therapyPoland6
1178cord tissue (Wharton's jelly)allo-unrelatedautismneurology2014experimental therapyPoland8
1179cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2014experimental therapyPoland24
1180cord tissue (Wharton's jelly)allo-unrelatedamyotrophic lateral sclerosisneurology2014experimental therapyPoland60
1181cord tissue (Wharton's jelly)allo-unrelatedcentral motor coordination impairment after hypoxic ischaemia lesion at birthneurology2014experimental therapyPoland2
1182cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2014experimental therapyPoland6
1183cord tissue (Wharton's jelly)allo-unrelatedautismneurology2014experimental therapyPoland12
1184cord tissue (Wharton's jelly)allo-unrelatedneuropathyneurology2014experimental therapyPoland23
1185cord tissue (Wharton's jelly)allo-unrelatedchronic graft versus host diseasehematology2013experimental therapyPoland17
1186cord tissue (Wharton's jelly)allo-unrelatedchronic graft versus host diseasehematology2013experimental therapyPoland18
1187cord tissue (Wharton's jelly)allo-unrelatedacute myeloid leukemiahematology2013experimental therapyPoland3
1188cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2013experimental therapyPoland3
1189cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2013experimental therapyPoland2
1190cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2013experimental therapyPoland18
1191cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2012experimental therapyPoland4
1192cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2012experimental therapyPoland7
1193cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2012experimental therapyPoland19
1194cord tissue (Wharton's jelly)allo-unrelatedacute graft versus host diseasehematology2011experimental therapyPoland17
1195bone marrowallogeneicFanconi Aplastic Anemiahematology2019standard therapyTurkey6
1196bone marrowallogeneicno datahematology2019standard therapyUnited Kingdom3
1197bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA66
1198bone marrowallogeneicaplastic anaemiahematology2019standard therapyRomania8
1199bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyPoland5
1200bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA52
1201bone marrowallogeneicno datahematology2019standard therapyItaly59
1202bone marrowallogeneicaplastic anaemiahematology2019standard therapyCanada18
1203bone marrowallogeneicacute lymphoblastic leukemia relapsehematology2018standard therapyGermany14
1204bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyCanada53
1205bone marrowallogeneicsevere combined immunodeficiencyhematology2018standard therapyTurkey21
1206bone marrowallogeneicno datahematology2018standard therapyBrazil1
1207bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA60
1208bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA22
1209bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyCanada37
1210bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyCanada18
1211bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyIran6
1212bone marrowallogeneiccongenital hypoplastic anemiahematology2018standard therapyCanada2
1213bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyGermany20
1214bone marrowallogeneicFanconi anaemiahematology2018standard therapyBrazil3
1215bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany6
1216bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA40
1217bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA72
1218bone marrowallogeneicno datahematology2018standard therapyUSA1
1219bone marrowallogeneicchronic granulomatous diseasehematology2018standard therapyGermany1
1220bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyUSA31
1221bone marrowallogeneicno datahematology2018standard therapyGermany52
1222bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA12
1223bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyUSA2
1224bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyAustralia59
1225bone marrowallogeneicother non-malignant diseasehematology2018standard therapyUSA29
1226bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyUnited Kingdom6
1227bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyPoland18
1228bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyPoland8
1229bone marrowallogeneicsevere combined immunodeficiencyhematology2018standard therapyPolandbelow 1
1230bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly14
1231bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyItaly70
1232bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyHungary4
1233bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyItaly4
1234bone marrowallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA62
1235bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA66
1236bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyCanada25
1237bone marrowallogeneicchronic granulomatous diseasehematology2018standard therapyUSA2
1238bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA17
1239bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA32
1240bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyAustria8
1241bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland7
1242bone marrowallogeneicT-cell leukemia/lymphomahematology2018standard therapyArgentina10
1243bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyBelgium41
1244bone marrowallogeneicthalassemia majorhematology2018standard therapyTurkey12
1245bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyItaly66
1246bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyPoland3
1247bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyIndia27
1248bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA49
1249bone marrowallogeneicaplastic anaemiahematology2018standard therapyPoland24
1250bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyUSA70
1251bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyFrance2
1252bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyItaly71
1253bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA8
1254bone marrowallogeneicHurler syndromehematology2018standard therapyUSA2
1255bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyGermany12
1256bone marrowallogeneicFanconi anaemiahematology2018standard therapyUSA3
1257bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA1
1258bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyCanada8
1259bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA20
1260bone marrowallogeneicsevere combined immunodeficiencyhematology2018standard therapyUSA1
1261bone marrowallogeneicchronic granulomatous diseasehematology2018standard therapyUSA2
1262bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyArgentina14
1263bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA11
1264bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyItaly14
1265bone marrowallogeneicsevere combined immunodeficiencyhematology2018standard therapyIsrael2
1266bone marrowallogeneicdiffuse large B-cell lymphomahematology2018standard therapyGermany68
1267bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA50
1268bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyUSA19
1269bone marrowallogeneicthalassemia majorhematology2018standard therapySweden14
1270bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyItaly36
1271bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland12
1272bone marrowallogeneicno datahematology2018standard therapyGermany16
1273bone marrowallogeneicno datahematology2018standard therapySpain48
1274bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyBrazil3
1275bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapySwitzerland67
1276bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyItalybelow 1
1277bone marrowallogeneicbilineal leukemia -acute lymphoblastic leukemia, acute myelogenous leukemiahematology2018standard therapyBelarus2
1278bone marrowallogeneicHodgkin’s lymphomahematology2018standard therapyUSA31
1279bone marrowallogeneicjuvenile myelomonocytic leukemiahematology2018standard therapyHungary11
1280bone marrowallogeneicchronic granulomatous diseasehematology2018standard therapySwitzerland3
1281bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyItaly4
1282bone marrowallogeneicprimary Immunodeficiency, Nijmegen breakage syndromehematology2017standard therapyBelarus6
1283bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA19
1284bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyHungary7
1285bone marrowallogeneicFanconi anaemiahematology2017standard therapyBelarus10
1286bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyTurkey8
1287bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyFrance2
1288bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA18
1289bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyIndia7
1290bone marrowallogeneicsecondary acute myelogenous leukemia after Ewing sarcomahematology2017standard therapyGermany16
1291bone marrowallogeneicNijmegen breakage syndromehematology2017standard therapyPoland8
1292bone marrowallogeneicmyelodysplastic syndromehematology2017standard therapyNorway2
1293bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyFrance12
1294bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly2
1295bone marrowallogeneicother combined immunodeficiencyhematology2017standard therapyUSA11
1296bone marrowallogeneicmyeloma multiplexhematology2017standard therapyCanada50
1297bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly7
1298bone marrowallogeneicT-cell leukemia/lymphomahematology2017standard therapyIran18
1299bone marrowallogeneicWiskott-Aldrich syndromehematology2017standard therapyIran2
1300bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly4
1301bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyBrazil14
1302bone marrowallogeneicno datahematology2017standard therapyFrance32
1303bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly9
1304bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom8
1305bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyPoland1
1306bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyFrance24
1307bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyRussia54
1308bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly56
1309bone marrowallogeneicchronic myeloid leukemiahematology2017standard therapyUSA51
1310bone marrowallogeneicacute megakaryocytic leukemiahematology2017standard therapySpain2
1311bone marrowallogeneicjuvenile myelomonocytic leukemiahematology2017standard therapyFinland1
1312bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA51
1313bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA17
1314bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA10
1315bone marrowallogeneicFanconi anaemiahematology2017standard therapyRussia10
1316bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA60
1317bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyCzech Republic68
1318bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly10
1319bone marrowallogeneicthalassemia majorhematology2017standard therapyTurkey11
1320bone marrowallogeneicpure red cell aplasiahematology2017standard therapyUSA5
1321bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA57
1322bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly59
1323bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyRussia1
1324bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyAustria3
1325bone marrowallogeneichyper IgM syndromehematology2017standard therapyFinland2
1326bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyTurkey2
1327bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA21
1328bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyRussia59
1329bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyCanada1
1330bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom9
1331bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly38
1332bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly13
1333bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyLithuania1
1334bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland16
1335bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA67
1336bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly55
1337bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyTurkey6
1338bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyHungary14
1339bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom10
1340bone marrowallogeneicleukemiahematology2017standard therapyUSA40
1341bone marrowallogeneicchronic granulomatous diseasehematology2017standard therapyPoland4
1342bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyRussia30
1343bone marrowallogeneicmyelodysplastic syndromehematology2017standard therapyUSA61
1344bone marrowallogeneicmyelodysplastic syndromehematology2017standard therapyItaly60
1345bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyGermany65
1346bone marrowallogeneicchronic granulomatous diseasehematology2017standard therapyPoland2
1347bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyTurkey22
1348bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyGermany76
1349bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland6
1350bone marrowallogeneichigh-risk acute lymphoblastic leukemiahematology2016standard therapyPoland18
1351bone marrowallogeneicanaemiahematology2016standard therapyItaly5
1352bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyGermany6
1353bone marrowallogeneicanaemiahematology2016standard therapyGermany16
1354bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyFinland45
1355bone marrowallogeneicjuvenile myelomonocytic leukemiahematology2016standard therapyGermany3
1356bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyBelarus15
1357bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyCzech Republic9
1358bone marrowallogeneicDiamond-Balckfan anaemiahematology2016standard therapyGermany2
1359bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyIreland39
1360bone marrowallogeneicmyeloproliferative syndromehematology2016standard therapyPoland22
1361bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyCroatia33
1362bone marrowallogeneicaplastic anaemiahematology2016standard therapyAustria20
1363bone marrowallogeneicnon-Hodgkin lymphomahematology2016standard therapyItaly46
1364bone marrowallogeneicno datan/a2016standard therapyPoland33
1365bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyPoland5
1366bone marrowallogeneicsevere combined immunodeficiencyhematology2016standard therapyGermany12
1367bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyNew Zealand1
1368bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyBelarus25
1369bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyUnited Kingdom29
1370bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyFrance5
1371bone marrowallogeneicFanconi anaemiahematology2016standard therapyNetherlands41
1372bone marrowallogeneicmyelodysplastic syndromehematology2016standard therapySpain56
1373bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyItaly67
1374bone marrowallogeneicmyelodysplastic syndromehematology2016standard therapyHungary1
1375bone marrowallogeneicsevere aplastic anaemia / paroxymal nocturnal haemoglobinuriahematology2016standard therapyPoland17
1376bone marrowallogeneicsevere aplastic anaemiahematology2016standard therapyFrance9
1377bone marrowallogeneicsevere combined immunodeficiencyhematology2016standard therapyPolandbelow 1
1378bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyBelarus18
1379bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyBelarus12
1380bone marrowallogeneicHodgkin’s lymphomahematology2016standard therapyItaly17
1381bone marrowallogeneicDiGeorge syndromehematology2016standard therapyNetherlands24
1382bone marrowallogeneicmyelofibrosishematology2016standard therapyGermany31
1383bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyCanada11
1384bone marrowallogeneicsevere combined immunodeficiencyhematology2016standard therapyTurkey4
1385bone marrowallogeneicHurler syndromemetabolic2016standard therapyUnited Kingdom2
1386bone marrowallogeneicno datan/a2016standard therapyPoland7
1387bone marrowallogeneicsevere aplastic anaemiahematology2016standard therapyFrance9
1388bone marrowallogeneicosteopetrosismetabolic2016standard therapyGermany1
1389bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyGermany7
1390bone marrowallogeneicbiphenotypic leukemiahematology2016standard therapyBrazil27
1391bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyItaly14
1392bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyItaly64
1393bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyItaly6
1394bone marrowallogeneicFanconi anaemiahematology2016standard therapyEstonia7
1395bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapySpain55
1396bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyItaly9
1397bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyItaly64
1398bone marrowallogeneicno datan/a2016standard therapyItaly3
1399bone marrowallogeneicT-cell acute lymphoblastic leukemiahematology2016standard therapyItaly4
1400bone marrowallogeneicsevere combined immunodeficiencyhematology2016standard therapyRomania2
1401bone marrowallogeneicosteopetrosismetabolic2016standard therapyRussia6
1402peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyIreland38
1403peripheral bloodallogeneicmyeloma multiplexhematology2019standard therapyFinland48
1404peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyAustralia57
1405peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2019standard therapyTurkey54
1406peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyPoland62
1407peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany53
1408peripheral bloodallogeneicno datahematology2019standard therapyPoland43
1409peripheral bloodallogeneicchronic lymphocytic leukemiahematology2019standard therapyUSA65
1410peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyIstanbul4
1411peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA55
1412peripheral bloodallogeneicchronic lymphocytic leukemiahematology2019standard therapyUSA58
1413peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland36
1414peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland54
1415peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyBelgium62
1416peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany37
1417peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland62
1418peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA66
1419peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany53
1420peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyTurkey39
1421peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCzech Republic65
1422peripheral bloodallogeneicsevere aplastic anaemiahematology2019standard therapyChile12
1423peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany63
1424peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom38
1425peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA67
1426peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA66
1427peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2018standard therapyGreece46
1428peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyFrance67
1429peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA62
1430peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA14
1431peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany24
1432peripheral bloodallogeneicno datahematology2018standard therapyLithuania46
1433peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyPoland60
1434peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA61
1435peripheral bloodallogeneicperipheral T-cell lymphomahematology2018standard therapyGermany50
1436peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany63
1437peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGreece47
1438peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland41
1439peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA58
1440peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyFrance8
1441peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyLithuania9
1442peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGreece45
1443peripheral bloodallogeneicno datahematology2018standard therapyGermany67
1444peripheral bloodallogeneicatypical chronic myeloid leukemiahematology2018standard therapyUSA58
1445peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyGermany52
1446peripheral bloodallogeneicHodgkin’s lymphomahematology2018standard therapyPoland27
1447peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyTurkey61
1448peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyItaly62
1449peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySlovakia56
1450peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland55
1451peripheral bloodallogeneicmyelodysplastic syndrome - RAEBhematology2018standard therapyGermany61
1452peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany34
1453peripheral bloodallogeneicmyelofibrosishematology2018standard therapyPoland53
1454peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2018standard therapyLithuania52
1455peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGreece46
1456peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany55
1457peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyRomania37
1458peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyItaly49
1459peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA72
1460peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA20
1461peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGreece43
1462peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA75
1463peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2018standard therapyGermany34
1464peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyPoland54
1465peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland8
1466peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyArgentina25
1467peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland59
1468peripheral bloodallogeneicnon-Hodgkin lymphoma, diffuse large B-cell lymphomahematology2018standard therapyGermany62
1469peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2018standard therapySlovakia40
1470peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBulgaria57
1471peripheral bloodallogeneicChronic granulomatous diseasehematology2018standard therapyRussia2
1472peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland63
1473peripheral bloodallogeneicno datahematology2018standard therapyMacedonia22
1474peripheral bloodallogeneicmyelofibrosishematology2018standard therapyUSA72
1475peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2018standard therapyGermany34
1476peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland40
1477peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUnited Kingdom69
1478peripheral bloodallogeneicHypoplastic MDS-EB2 with incipient sAMLhematology2018standard therapyGermany63
1479peripheral bloodallogeneicno datahematology2018standard therapyGermany65
1480peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA59
1481peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyUSA13
1482peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany54
1483peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA66
1484peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA54
1485peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA67
1486peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyGermany45
1487peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly48
1488peripheral bloodallogeneicplasma cell disorderhematology2018standard therapyFrance57
1489peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyPoland30
1490peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA68
1491peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyItaly4
1492peripheral bloodallogeneicchronic myeloid leukemiahematology2018standard therapyUnited Kingdom41
1493peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyNetherlands67
1494peripheral bloodallogeneicsevere combined immunodeficiencyhematology2018standard therapyPoland2
1495peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyFrance34
1496peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA64
1497peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyUSA67
1498peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyBelgium49
1499peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyFrance30
1500peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany60
1501peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany52
1502peripheral bloodallogeneicprolymphocytic leukemiahematology2018standard therapyUSA62
1503peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance32
1504peripheral bloodallogeneicB-cell Chronic lymphoblastic leukemiahematology2018standard therapyGermany65
1505peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapySpain46
1506peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyCzech Republic57
1507peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany55
1508peripheral bloodallogeneicno datahematology2018standard therapyBelgium58
1509peripheral bloodallogeneicno datahematology2018standard therapyGermany19
1510peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyItaly60
1511peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland45
1512peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany58
1513peripheral bloodallogeneicmyeloproliferative neoplasmshematology2018standard therapyGermany61
1514peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapySpain51
1515peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyCanada60
1516peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany59
1517peripheral bloodallogeneictherapy-related myelodysplastic syndromeshematology2018standard therapyGermany65
1518peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyGermany11
1519peripheral bloodallogeneicchronic myeloid leukemiahematology2018standard therapyUSA25
1520peripheral bloodallogeneicfollicular lymphoma (non-Hodgkin lymphoma)hematology2018standard therapyCzech Republic56
1521peripheral bloodallogeneicthalassemia majorhematology2018standard therapyGermany5
1522peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly44
1523peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyNetherlands31
1524peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA71
1525peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland48
1526peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland20
1527peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyRussia6
1528peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany56
1529peripheral bloodallogeneicchronic granulomatous diseasehematology2018standard therapyUSA15
1530peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland66
1531peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA49
1532peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany6
1533peripheral bloodallogeneicno datahematology2018standard therapyGermany60
1534peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA65
1535peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland57
1536peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA67
1537peripheral bloodallogeneicmyelofibrosishematology2018standard therapyUSA68
1538peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA36
1539peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom37
1540peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland29
1541peripheral bloodallogeneicother malignancyhematology2018standard therapyItaly59
1542peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany47
1543peripheral bloodallogeneicchronic myeloid leukemiahematology2018standard therapyUSA48
1544peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyCanada46
1545peripheral bloodallogeneicno datahematology2018standard therapyGermany64
1546peripheral bloodallogeneicprimary Immunodeficiencyhematology2018standard therapyRussia3
1547peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom55
1548peripheral bloodallogeneicrelapsed peripheral T cell lymphomahematology2018standard therapyCanada44
1549peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA62
1550peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA71
1551peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyCanada52
1552peripheral bloodallogeneicchronic lymphocytic leukemiahematology2018standard therapyItaly38
1553peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyCanada63
1554peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance28
1555peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA67
1556peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland69
1557peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyDenmark59
1558peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA63
1559peripheral bloodallogeneicno datahematology2018standard therapyCzech Republic22
1560peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany71
1561peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyUSA70
1562peripheral bloodallogeneicother myelodysplastic syndromeshematology2018standard therapyUSA67
1563peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyIsrael32
1564peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyAustria45
1565peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySweden60
1566peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA64
1567peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyPoland71
1568peripheral bloodallogeneicmyelofibrosishematology2018standard therapyBelgium64
1569peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland38
1570peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland59
1571peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyItaly58
1572peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland32
1573peripheral bloodallogeneicchronic lymphocytic leukemiahematology2018standard therapyPoland49
1574peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyTurkey60
1575peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany46
1576peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany25
1577peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA71
1578peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland31
1579peripheral bloodallogeneicchronic myeloid leukemiahematology2018standard therapySweden63
1580peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPolandbelow 1
1581peripheral bloodallogeneicfollicular lymphomahematology2018standard therapyLithuania44
1582peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA50
1583peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA17
1584peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland54
1585peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyPoland24
1586peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyBelgium27
1587peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA39
1588peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyNetherlands56
1589peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapySerbia39
1590peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyNetherlands66
1591peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySutherland59
1592peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyLithuania21
1593peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany67
1594peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland33
1595peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland70
1596peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySpain53
1597peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2018standard therapyGermany45
1598peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyUSA74
1599peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBrazil39
1600peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyGermany27
1601peripheral bloodallogeneicno datahematology2018standard therapyBrazil3
1602peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany58
1603peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBulgaria61
1604peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance40
1605peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA70
1606peripheral bloodallogeneicplasma cell disorderhematology2018standard therapyFrance64
1607peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyRussia33
1608peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA61
1609peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBrazil71
1610peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland55
1611peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA72
1612peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyHungary42
1613peripheral bloodallogeneicmyelofibrosishematology2018standard therapyCanada58
1614peripheral bloodallogeneicno datahematology2018standard therapyGermany38
1615peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyGermany63
1616peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA63
1617peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyBelgium32
1618peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyGermany56
1619peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyArgentina1
1620peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyGermany57
1621peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA62
1622peripheral bloodallogeneicblastic NK cell lymphomahematology2018standard therapyGermany65
1623peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance42
1624peripheral bloodallogeneicno datahematology2018standard therapyBelgium70
1625peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly3
1626peripheral bloodallogeneicno datahematology2018standard therapyFrance70
1627peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyItaly55
1628peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly8
1629peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany54
1630peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland33
1631peripheral bloodallogeneicdiffuse large B-cell lymphomahematology2018standard therapyPoland54
1632peripheral bloodallogeneicno datahematology2018standard therapyPoland69
1633peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland35
1634peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA57
1635peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyTurkey27
1636peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA66
1637peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany52
1638peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyLithuania39
1639peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany20
1640peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany67
1641peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA68
1642peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA73
1643peripheral bloodallogeneicsevere combined immunodeficiencyhematology2018standard therapyTurkey9
1644peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany67
1645peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA33
1646peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany60
1647peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland60
1648peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyCroatia59
1649peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany65
1650peripheral bloodallogeneicmyelodysplastic syndrome, acute myelogenous leukemiahematology2018standard therapyUSA74
1651peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom37
1652peripheral bloodallogeneicleukemiahematology2018standard therapyGermany34
1653peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA66
1654peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBelgium68
1655peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland28
1656peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland49
1657peripheral bloodallogeneicFanconi anaemiahematology2018standard therapyUSA9
1658peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyUSA63
1659peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA31
1660peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyGermany17
1661peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySweden60
1662peripheral bloodallogeneicmyelofibrosishematology2018standard therapySweden56
1663peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance25
1664peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyUSA39
1665peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA71
1666peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA60
1667peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA70
1668peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2018standard therapySwitzerland50
1669peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyCanada23
1670peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA69
1671peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyGermany77
1672peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA58
1673peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany8
1674peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany38
1675peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland64
1676peripheral bloodallogeneicprimary myelofibrosis, secondary acute myelogenous leukemiahematology2018standard therapyGermany53
1677peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland50
1678peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA76
1679peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA46
1680peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyItaly61
1681peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyUSA57
1682peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany64
1683peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySlovenia54
1684peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUnited Kingdom22
1685peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland67
1686peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA54
1687peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA8
1688peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA62
1689peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA68
1690peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2018standard therapyPoland13
1691peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2018standard therapyGermany41
1692peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyItaly62
1693peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland64
1694peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA47
1695peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA50
1696peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany61
1697peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany64
1698peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland51
1699peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany61
1700peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland59
1701peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA72
1702peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA54
1703peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany56
1704peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyNetherlands67
1705peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA42
1706peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland71
1707peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland30
1708peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyItaly67
1709peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA45
1710peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA45
1711peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA61
1712peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyFrance33
1713peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyFrance50
1714peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA72
1715peripheral bloodallogeneicmyelofibrosishematology2018standard therapyGermany60
1716peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySpain34
1717peripheral bloodallogeneicHodgkin’s lymphomahematology2018standard therapyPoland38
1718peripheral bloodallogeneicacute myeloid leukemia in first complete remissionhematology2018standard therapyGermany61
1719peripheral bloodallogeneicsecondary acute myelogenous leukemiahematology2018standard therapyPoland58
1720peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance46
1721peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland48
1722peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly65
1723peripheral bloodallogeneicother myleofibrosishematology2018standard therapyPoland57
1724peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland66
1725peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyPoland23
1726peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom46
1727peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA63
1728peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyLithuania56
1729peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2018standard therapyGermany7
1730peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyGermany18
1731peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA74
1732peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom42
1733peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUnited Kingdom29
1734peripheral bloodallogeneicmyelofibrosishematology2018standard therapyNetherlands49
1735peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyCanada59
1736peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany35
1737peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA26
1738peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland13
1739peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA71
1740peripheral bloodallogeneicno datahematology2017standard therapySwitzerland68
1741peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA8
1742peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland37
1743peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyBelgium26
1744peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland10
1745peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA70
1746peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2017standard therapyGermany60
1747peripheral bloodallogeneicmyelodysplastic syndrome in Fanconi anaemiahematology2017standard therapyItaly23
1748peripheral bloodallogeneicchronic myeloid leukemiahematology2017standard therapyUSA57
1749peripheral bloodallogeneicHodgkin’s lymphomahematology2017standard therapyUSA25
1750peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA72
1751peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom24
1752peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyGermany63
1753peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA72
1754peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyUSA69
1755peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyGermany57
1756peripheral bloodallogeneicmyeloma multiplexhematology2017standard therapyPoland38
1757peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland27
1758peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyUSA69
1759peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA40
1760peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyCanada22
1761peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA61
1762peripheral bloodallogeneicmyeloma multiplexhematology2017standard therapyUSA57
1763peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA64
1764peripheral bloodallogeneicno datahematology2017standard therapyCanada55
1765peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyFrance61
1766peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland58
1767peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2017standard therapyGermany72
1768peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA53
1769peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA71
1770peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyUSA55
1771peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA68
1772peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany46
1773peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyTurkey26
1774peripheral bloodallogeneicsecondary acute myelogenous leukemiahematology2017standard therapyAustria24
1775peripheral bloodallogeneicsevere aplastic anaemiahematology2017standard therapyRussia16
1776peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyIsrael6
1777peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA23
1778peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyIsrael37
1779peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany63
1780peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapySweden59
1781peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyGermany50
1782peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA63
1783peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA68
1784peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyNetherlands65
1785peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany55
1786peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA67
1787peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA66
1788peripheral bloodallogeneicno datahematology2017standard therapyPoland1
1789peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapySweden69
1790peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA53
1791peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland66
1792peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany52
1793peripheral bloodallogeneicblastic plasmacytoid dendritic cell neoplasmhematology2017standard therapyGermany56
1794peripheral bloodallogeneicmyelofibrosishematology2017standard therapyUSA47
1795peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany62
1796peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland24
1797peripheral bloodallogeneicprimary myelofibrosishematology2017standard therapyPoland32
1798peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyNetherlands71
1799peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2017standard therapyGermany64
1800peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland21
1801peripheral bloodallogeneicchronic lymphocytic leukemiahematology2017standard therapyGermany7
1802peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA57
1803peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA63
1804peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyAustralia43
1805peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyNorway56
1806peripheral bloodallogeneicchronic lymphocytic leukemiahematology2017standard therapyUSA51
1807peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyBelgium69
1808peripheral bloodallogeneicmyelofibrosishematology2017standard therapyNetherlands72
1809peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyFrance36
1810peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2017standard therapySpain28
1811peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2017standard therapyGreece28
1812peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA17
1813peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly16
1814peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA53
1815peripheral bloodallogeneicprolymphocytic leukemiahematology2017standard therapyPoland63
1816peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2017standard therapyItaly61
1817peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA63
1818peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany59
1819peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany62
1820peripheral bloodallogeneicprimary myelofibrosishematology2017standard therapyGermany29
1821peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyCanada46
1822peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany62
1823peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland56
1824peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany68
1825peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2017standard therapyUnited Kingdom51
1826peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyFinland58
1827peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyNetherlands53
1828peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyHungary40
1829peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA61
1830peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyRussia54
1831peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly57
1832peripheral bloodallogeneicother malignancyhematology2017standard therapyFrance59
1833peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyLithuania53
1834peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2017standard therapyGermany44
1835peripheral bloodallogeneicsevere aplastic anaemiahematology2017standard therapyPoland32
1836peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA22
1837peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA53
1838peripheral bloodallogeneicsevere aplastic anaemiahematology2017standard therapyPoland27
1839peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany49
1840peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany60
1841peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly64
1842peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany31
1843peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA57
1844peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland30
1845peripheral bloodallogeneicchronic myeloid leukemiahematology2017standard therapyUSA74
1846peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyPoland52
1847peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyGermany64
1848peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyBelgium70
1849peripheral bloodallogeneicno datahematology2017standard therapyPoland53
1850peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany35
1851peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA51
1852peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany65
1853peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland60
1854peripheral bloodallogeneicprimary Immunodeficiencyhematology2017standard therapyRussia2
1855peripheral bloodallogeneicmyelofibrosishematology2017standard therapyUSA62
1856peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyRussia49
1857peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyCanada41
1858peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland52
1859peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA76
1860peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany68
1861peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyCanada55
1862peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2017standard therapyAustralia25
1863peripheral bloodallogeneicno datahematology2017standard therapyPoland58
1864peripheral bloodallogeneicmyeloproliferative neoplasmshematology2017standard therapyPoland7
1865peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland42
1866peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyCanada4
1867peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyIsrael11
1868peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyNetherlands69
1869peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyUSA68
1870peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland43
1871peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapySwitzerland67
1872peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland19
1873peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA69
1874peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyNetherlands51
1875peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA58
1876peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly67
1877peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2017standard therapyUSA58
1878peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA65
1879peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA62
1880peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyFrance39
1881peripheral bloodallogeneicprimary Immunodeficiencyhematology2017standard therapyRussia4
1882peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyFrance63
1883peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyFrance63
1884peripheral bloodallogeneicno datahematology2017standard therapyKanada32
1885peripheral bloodallogeneicmyelofibrosishematology2017standard therapyUSA62
1886peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2017standard therapyPoland7
1887peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyPoland36
1888peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyHungary32
1889peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland38
1890peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland38
1891peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyGermany49
1892peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany60
1893peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyNetherlands51
1894peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyTurkey54
1895peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyTurkey58
1896peripheral bloodallogeneicno datahematology2017standard therapyRussia36
1897peripheral bloodallogeneicchronic granulomatous diseasehematology2017standard therapyPoland4
1898peripheral bloodallogeneicno datahematology2017standard therapyGermany65
1899peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany29
1900peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyCzech Republic12
1901peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyGermany63
1902peripheral bloodallogeneicmyelofibrosishematology2017standard therapyGermany29
1903peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyFinland46
1904peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland35
1905peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapySlovakia54
1906peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA23
1907peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyFrance65
1908peripheral bloodallogeneicprolymphocytic leukemiahematology2017standard therapyBelgium38
1909peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA54
1910peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly39
1911peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA69
1912peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA64
1913peripheral bloodallogeneicother myleofibrosishematology2017standard therapyUSA71
1914peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA35
1915peripheral bloodallogeneicchronic lymphocytic leukemiahematology2017standard therapyUSA65
1916peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyCanada63
1917peripheral bloodallogeneicfollicular CAhematology2017standard therapySouth Africa42
1918peripheral bloodallogeneicacute myelogenous leukemia with myelodysplastic syndromehematology2017standard therapyGermany64
1919peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyCzech Republic62
1920peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany55
1921peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland53
1922peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyCzech Republic48
1923peripheral bloodallogeneicβ - thalassemia majorhematology2017standard therapyIndia4
1924peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA67
1925peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyCanada67
1926peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyPoland59
1927peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland62
1928peripheral bloodallogeneicmyelofibrosishematology2017standard therapyUnited Kingdom55
1929peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland59
1930peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland52
1931peripheral bloodallogeneicmyeloproliferative neoplasmshematology2017standard therapyPoland7
1932peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA68
1933peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyBelgium34
1934peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA70
1935peripheral bloodallogeneicchronic lymphocytic leukemiahematology2017standard therapyEstonia67
1936peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2017standard therapyAustralia30
1937peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA51
1938peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA69
1939peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapySwitzerland75
1940peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyLithuania65
1941peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyCanada56
1942peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly55
1943peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyFrance56
1944peripheral bloodallogeneicosteopetrosishematology2017standard therapyIsrael3
1945peripheral bloodallogeneicchronic lymphocytic leukemiahematology2017standard therapyPoland47
1946peripheral bloodallogeneicB-cell Chronic lymphoblastic leukemiahematology2017standard therapyGermany48
1947peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany65
1948peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyGermany56
1949peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland64
1950peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA33
1951peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyGermany67
1952peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany53
1953peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyAustralia60
1954peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA63
1955peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyUSA42
1956peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyFrance75
1957peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly32
1958peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2017standard therapyGermany54
1959peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyItaly58
1960peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyCanada57
1961peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyGermany50
1962peripheral bloodallogeneicmyelofibrosishematology2017standard therapyUSA62
1963peripheral bloodallogeneicaplastic anaemiahematology2017standard therapyUnited Kingdom23
1964peripheral bloodallogeneicno datahematology2017standard therapyPoland39
1965peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyBelgium55
1966peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyTurkey46
1967peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyBelgium71
1968peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany64
1969peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyUSA65
1970peripheral bloodallogeneicchronic lymphocytic leukemiahematology2017standard therapyUSA45
1971peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyBelgium19
1972peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyNorway57
1973peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyBrazil12
1974peripheral bloodallogeneichemophagocytosishematology2017standard therapyUSA52
1975peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly45
1976peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyLithuania59
1977peripheral bloodallogeneicmyeloma multiplexhematology2017standard therapyGermany56
1978peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland60
1979peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapySweden63
1980peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly61
1981peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyNetherlands75
1982peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyNetherlands66
1983peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA53
1984peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyPoland46
1985peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUSA44
1986peripheral bloodallogeneicmyelofibrosishematology2017standard therapyGermany66
1987peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyCroatia64
1988peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapySpain20
1989peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland3
1990peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyItaly47
1991peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyFrance56
1992peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly48
1993peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyFrance43
1994peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyGermany47
1995peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA53
1996peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyRussia32
1997peripheral bloodallogeneicchronic lymphocytic leukemiahematology2017standard therapyBelgium57
1998peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapySlovakia64
1999peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA75
2000peripheral bloodallogeneicLangerhans Lymphohistiocytosishematology2017standard therapyCzech Republic2
2001peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyPoland54
2002peripheral bloodallogeneicno datan/a2017standard therapyFrance39
2003peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyHungary47
2004peripheral bloodallogeneicmyelofibrosishematology2017standard therapyDenmark63
2005peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyAustria54
2006peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyItaly48
2007peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyUSA56
2008peripheral bloodallogeneicdiffuse large B-cell lymphomahematology2017standard therapyGermany61
2009peripheral bloodallogeneicmyelofibrosishematology2017standard therapySpain63
2010peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyFrance65
2011peripheral bloodallogeneicCommon variable immunodeficiency, relapsed hemophagocytic syndromehematology2017standard therapyGermany44
2012peripheral bloodallogeneicnon-Hodgkin lymphomahematology2017standard therapyUSA63
2013peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyPoland3
2014peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyIran17
2015peripheral bloodallogeneicNiemann–Pick diseasehematology2017standard therapyPoland2
2016peripheral bloodallogeneicsevere aplastic anaemiahematology2017standard therapyPoland14
2017peripheral bloodallogeneicchronic myeloid leukemiahematology2017standard therapyTurkey29
2018peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyFrance68
2019peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland43
2020peripheral bloodallogeneicchronic myeloproliferative neoplasm blast crisishematology2017standard therapyGermany29
2021peripheral bloodallogeneicacute myelogenous leukemiahematology2017standard therapyUnited Kingdom51
2022peripheral bloodallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA24
2023peripheral bloodallogeneicmyelodysplastic syndromehematology2017standard therapyPoland60
2024peripheral bloodallogeneicmyeloma multiplexhematology2017standard therapyGermany44
2025peripheral bloodallogeneicHurler syndromehematology2017standard therapyUnited Kingdom2
2026peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany66
2027peripheral bloodallogeneicsevere aplastic anaemiahematology2016standard therapyRussia18
2028peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyFrance35
2029peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyUSA69
2030peripheral bloodallogeneicT-cell-prolymphocytic leukemiahematology2016standard therapyUnited Kingdom61
2031peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland19
2032peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyItaly63
2033peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany62
2034peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany67
2035peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyCanada47
2036peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyUnited Kingdom47
2037peripheral bloodallogeneicplasma cell disorderhematology2016standard therapyFrance54
2038peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapySpain50
2039peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyItaly21
2040peripheral bloodallogeneicnon-Hodgkin lymphomahematology2016standard therapyNetherlands39
2041peripheral bloodallogeneicacute myelogenous leukemia M2/M4hematology2016standard therapyGermany59
2042peripheral bloodallogeneichigh-risk acute lymphoblastic leukemiahematology2016standard therapyPoland5
2043peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyItaly58
2044peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyGermany33
2045peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyItaly30
2046peripheral bloodallogeneiccomposite lymphomahematology2016standard therapyGermany51
2047peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland55
2048peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany62
2049peripheral bloodallogeneicnon-Hodgkin lymphomahematology2016standard therapyRussia32
2050peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany59
2051peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyRussia44
2052peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany37
2053peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany15
2054peripheral bloodallogeneicchronic myeloid leukemiahematology2016standard therapyGermany40
2055peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyGreece9
2056peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland24
2057peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland54
2058peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyFrance56
2059peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany63
2060peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyUnited Kingdom68
2061peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany72
2062peripheral bloodallogeneicnon-Hodgkin lymphomahematology2016standard therapyPoland58
2063peripheral bloodallogeneicB-cell Acute lymphoblastic leukemiahematology2016standard therapyBelgium44
2064peripheral bloodallogeneicmyelofibrosishematology2016standard therapyFrance67
2065peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyPoland20
2066peripheral bloodallogeneicnon-Hodgkin lymphomahematology2016standard therapyRussia38
2067peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyItaly66
2068peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland50
2069peripheral bloodallogeneicchronic myeloid leukemiahematology2016standard therapyFinland46
2070peripheral bloodallogeneicSAA / Amyloidosishematology2016standard therapyUnited Kingdom45
2071peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyFrance59
2072peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPortugal41
2073peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany65
2074peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyAustralia62
2075peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyNew Zealand59
2076peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyAustria61
2077peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyPoland39
2078peripheral bloodallogeneicmyeloma multiplexhematology2016standard therapyPoland38
2079peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyBelgium9
2080peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapySlovakia30
2081peripheral bloodallogeneiclymphoblastic lymphomahematology2016standard therapyItaly33
2082peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyItaly53
2083peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland65
2084peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyFrance28
2085peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyTurkey51
2086peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany61
2087peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyFrance60
2088peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyBrazil37
2089peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyUnited Kingdom20
2090peripheral bloodallogeneicprimary myelofibrosishematology2016standard therapySwitzerland67
2091peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2016standard therapyAustria41
2092peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyCzech Republic60
2093peripheral bloodallogeneicno datan/a2016standard therapyPoland44
2094peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyFrance63
2095peripheral bloodallogeneicmyeloproliferative syndromehematology2016standard therapyPoland52
2096peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2016standard therapySerbia21
2097peripheral bloodallogeneicleukemiahematology2016standard therapyLithuania53
2098peripheral bloodallogeneicno datan/a2016standard therapyTurkey4
2099peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2016standard therapyFinland53
2100peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyItaly52
2101peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapySpain15
2102peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyDenmark68
2103peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany66
2104peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyIsrael36
2105peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapySwitzerlandbelow 1
2106peripheral bloodallogeneicmyelofibrosishematology2016standard therapyNetherlands66
2107peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyBelgium65
2108peripheral bloodallogeneicmyelodysplastic syndrome - RCMDhematology2016standard therapyCzech Republic32
2109peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany59
2110peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyUnited Kingdom68
2111peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2016standard therapyGermany19
2112peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyFrance32
2113peripheral bloodallogeneicno datan/a2016standard therapyPoland55
2114peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyFrance67
2115peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany61
2116peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyTurkey48
2117peripheral bloodallogeneicHodgkin’s lymphomahematology2016standard therapyNetherlands38
2118peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany18
2119peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland46
2120peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany65
2121peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyTurkey38
2122peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany66
2123peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyTurkey37
2124peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyIsrael63
2125peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyTurkey55
2126peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyPoland30
2127peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyGermany27
2128peripheral bloodallogeneicHodgkin’s lymphomahematology2016standard therapyGermany32
2129peripheral bloodallogeneicchronic myeloid leukemiahematology2016standard therapyGermany62
2130peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyLithuania23
2131peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapySpain38
2132peripheral bloodallogeneicno datan/a2016standard therapyNetherlands58
2133peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyAustralia51
2134peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany69
2135peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyUnited Kingdom62
2136peripheral bloodallogeneicprimary Immunodeficiencyhematology2016standard therapyRussia5
2137peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyItaly51
2138peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyHungary20
2139peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyHungary46
2140peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyEstonia62
2141peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapySpain58
2142peripheral bloodallogeneicmyeloma multiplexhematology2016standard therapyPoland51
2143peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany72
2144peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany35
2145peripheral bloodallogeneicplasma cell disorderhematology2016standard therapyFrance47
2146peripheral bloodallogeneicFanconi anaemiahematology2016standard therapyEstonia7
2147peripheral bloodallogeneicmyeloma multiplexhematology2016standard therapyGermany63
2148peripheral bloodallogeneicchronic myelomonocytic leukemia, minimal residual diseasehematology2016standard therapyPoland50
2149peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyFrance52
2150peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyFrance38
2151peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyBelgium56
2152peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyHungary57
2153peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyCanada13
2154peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyFrance24
2155peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyCzech Republic37
2156peripheral bloodallogeneicHodgkin’s lymphomahematology2016standard therapyUnited Kingdom18
2157peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyLithuania15
2158peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyFrance67
2159peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyFrance47
2160peripheral bloodallogeneicchronic lymphocytic leukemiahematology2016standard therapyGermany62
2161peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany66
2162peripheral bloodallogeneicno datan/a2016standard therapyFrance59
2163peripheral bloodallogeneicno datan/a2016standard therapyGermany17
2164peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyIreland47
2165peripheral bloodallogeneicprimary myelofibrosishematology2016standard therapyGermany67
2166peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyAustralia61
2167peripheral bloodallogeneicmyelofibrosishematology2016standard therapyIsrael72
2168peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany73
2169peripheral bloodallogeneicaplastic anaemiahematology2016standard therapyUnited Kingdom23
2170peripheral bloodallogeneicno datan/a2016standard therapyCzech Republic59
2171peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany43
2172peripheral bloodallogeneicT Cell Lymphoma/ NOS - Not otherwise specifiedhematology2016standard therapyGermany55
2173peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany66
2174peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany32
2175peripheral bloodallogeneicHodgkin’s lymphomahematology2016standard therapyGermany32
2176peripheral bloodallogeneicno datan/a2016standard therapySweden58
2177peripheral bloodallogeneicmyelodysplastic syndrome - RAEBhematology2016standard therapyPoland56
2178peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland40
2179peripheral bloodallogeneicrefractory anemia with excess blastshematology2016standard therapyUnited Kingdom62
2180peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyBelgium46
2181peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapySlovakia8
2182peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany13
2183peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland42
2184peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland64
2185peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyGermany50
2186peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyCzech Republic49
2187peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyFrance32
2188peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyCzech Republic56
2189peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany29
2190peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany46
2191peripheral bloodallogeneicno datan/a2016standard therapyGermany71
2192peripheral bloodallogeneicno datan/a2016standard therapyBelgium30
2193peripheral bloodallogeneicWiskott-Aldrich syndromehematology2016standard therapyPoland1
2194peripheral bloodallogeneicno datan/a2016standard therapyCzech Republic1
2195peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapySweden35
2196peripheral bloodallogeneicno datan/a2016standard therapyPoland28
2197peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyItaly31
2198peripheral bloodallogeneicadrenoleukodystrophymetabolic2016standard therapyPoland1
2199peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland18
2200peripheral bloodallogeneicprimary myelofibrosishematology2016standard therapyGermany50
2201peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland54
2202peripheral bloodallogeneicT-cell leukemia/lymphomahematology2016standard therapyCanada31
2203peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyCzech Republic54
2204peripheral bloodallogeneicHodgkin’s lymphomahematology2016standard therapyPoland31
2205peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany64
2206peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyColumbia43
2207peripheral bloodallogeneicno datan/a2016standard therapyNetherlands69
2208peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyGermany66
2209peripheral bloodallogeneicchronic lymphocytic leukemiahematology2016standard therapySweden61
2210peripheral bloodallogeneicX-linked lymphoproliferative diseasehematology2016standard therapyRussia12
2211peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyPoland18
2212peripheral bloodallogeneicno datan/a2016standard therapyPoland43
2213peripheral bloodallogeneicno datan/a2016standard therapyNetherlands70
2214peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyFrance40
2215peripheral bloodallogeneicchronic lymphocytic leukemiahematology2016standard therapySlovakia52
2216peripheral bloodallogeneicno datan/a2016standard therapyCzech Republic45
2217peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyAustralia62
2218peripheral bloodallogeneicmyelodysplastic syndromehematology2016standard therapyAustria60
2219peripheral bloodallogeneicacute lymphoblastic leukemiahematology2016standard therapyPoland56
2220peripheral bloodallogeneicacute myelogenous leukemiahematology2016standard therapyUnited Kingdom58
2221adipose tissueautologousscardermatology2019clinical trialPolandno data
2222adipose tissueautologouscutis laxadermatology2019clinical trialPolandno data
2223adipose tissueautologouscoxarthrosisorthopedics2019transplantationPoland34
2224adipose tissueautologousscardermatology2019clinical trialPolandno data
2225adipose tissueautologousscardermatology2019clinical trialPolandno data
2226adipose tissueautologousscardermatology2018clinical trialPolandno data
2227adipose tissueautologouscutis laxadermatology2018clinical trialPolandno data
2228adipose tissueautologouscutis laxadermatology2018clinical trialPolandno data
2229adipose tissueautologousscardermatology2018clinical trialPolandno data
2230adipose tissueautologousscardermatology2018clinical trialPolandno data
2231adipose tissueautologousscardermatology2018clinical trialPolandno data
2232adipose tissueautologousscardermatology2018clinical trialPolandno data
2233adipose tissueautologouscutis laxadermatology2018clinical trialPolandno data
2234adipose tissueautologousscardermatology2018clinical trialPolandno data
2235adipose tissueautologouscutis laxadermatology2018clinical trialPolandno data
2236adipose tissueautologouscutis laxadermatology2018clinical trialPolandno data
2237adipose tissueautologouscutis laxadermatology2018clinical trialPolandno data
2238adipose tissueautologousscardermatology2018clinical trialPolandno data
2239adipose tissueautologousscardermatology2018clinical trialPolandno data
2240adipose tissueautologousscardermatology2018clinical trialPolandno data
2241adipose tissueautologouscutis laxadermatology2018clinical trialPolandno data
2242adipose tissueautologouscutis laxadermatology2018clinical trialPolandno data
2243adipose tissueautologousscardermatology2018clinical trialPolandno data
2244adipose tissueautologousscardermatology2018clinical trialPolandno data
2245adipose tissueautologouscondition after injury of the left knee jointOrthopedics2018transplantationPoland33
2246adipose tissueautologousgonarthrosisOrthopedics2018transplantationPoland42
2247adipose tissueautologousgonarthrosisOrthopedics2018transplantationPoland69
2248adipose tissueautologouscoxarthrosisOrthopedics2018transplantationPoland53
Ultima actualizare: 21 martie 2019